Domino Data Labs’ expanded platform includes a new project hub, additional cloud offerings, and the Model Sentry solution suite.
The next Cannabis Science Conference Fall meeting is soliciting a call for abstracts.
The $87.5 million purchase grants Novartis rights to an investigational gene therapy program intended for treatment of cystinosis.
The guidance describes FDA’s current recommendations regarding adjusting for covariates in statistical analysis of randomized clinical trials.
Context surrounding the Inflation Reduction Act is necessary for a comprehensive understanding of the global biopharma market.
ProBioGen’s Lenti.RiGHT is a lentivirus production platform for use in gene transfer applications.
Astellas and Sony will collaborate to discover a novel ADC platform for use in oncology.
Avirmax’s new gene therapy facility in Hayward, Calif., will specialize in AAV gene therapy research and development.
In a brief, the Federal Trade Commission cited concerns about the acquisition resulting in an increased monopoly on Amgen’s newly acquired thyroid eye disease and chronic refractory gout treatments.
The NSF-sponsored program aims to help partners collaborate to create opportunities for significant economic, societal, and technological opportunities for growth in their regions.